MPX Raises US$40 Million Secured Convertible Loan to Fund Capacity Development of MPX Assets and Acquisitions
May 29, 2018 08:20 ET
|
MPX Bioceutical Corporation
TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed a US$40,000,000 secured...
MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda
April 17, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has signed a letter of intent (the “LOI”) to...
MPX Adds a Fourth Dispensary in Phoenix and Triples Capacity for MPX Concentrate Production in Arizona
April 09, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health for...
Mpx Enjoys Record Monthly Revenue of Cdn$5.2 Million in Arizona
April 03, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) has reported that its managed Arizona assets have recorded their best revenue...
MPX Bioceutical Corporation to Host Investor Conference Call on March 8, 2018
March 05, 2018 16:57 ET
|
MPX Bioceutical Corporation
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to provide an operational and financial update to...
MPX Signs Definitive Agreement to Expand Its Footprint in Arizona
March 05, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the Company, through its wholly-owned U.S....
MPX Reports Q3 Fiscal 2018 Results
March 01, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31,...
MPX Announces Inclusion in Horizons Emerging Marijuana Growers Index ETF
February 12, 2018 17:00 ET
|
MPX Bioceutical Corporation
TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging...
MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland
January 31, 2018 17:00 ET
|
MPX Bioceutical Corporation
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the Company, through its indirect wholly-owned...
MPX Appoints New Chief Financial Officer
January 16, 2018 07:00 ET
|
MPX Bioceutical Corporation
TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new...